Mannose-1-phosphate
Structural formula | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||
α- anomer of D- mannose-1-phosphate ( pyranose form ) | |||||||||||||
General | |||||||||||||
Surname | Mannose-1-phosphate | ||||||||||||
other names |
M1P |
||||||||||||
Molecular formula | C 6 H 13 O 9 P | ||||||||||||
External identifiers / databases | |||||||||||||
|
|||||||||||||
properties | |||||||||||||
Molar mass | 290.16 g mol −1 | ||||||||||||
safety instructions | |||||||||||||
|
|||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Mannose-1-phosphate is a phosphoric acid ester of mannose and the isomer of mannose-6-phosphate . It is an intermediate in the provision of mannose for glycosylation of proteins and lipids . Physiologically, only the D isomer plays a role.
meaning
Mannose-1-phosphate is used for the synthesis of GDP-mannose (or dolicholmonophosphate mannose , Dol-P-Man), which in turn is used as "activated" mannose for the synthesis of a large number of polysaccharides (for example xanthan gum ), GPI anchors and glycans. In the latter, a so-called mannosylation takes place on proteins ( O- mannosylation), i.e. the attachment of mannose to threonine or serine residues ( glycosylation ). C-mannosylated proteins also require GDP-mannose.
In addition, the “activated” L - fucose ( GDP-fucose ) is formed from GDP-mannose .
Mannose-1-phosphate cannot pass through cell membranes and it is not transported into the cell.
Reactions
The enzyme phosphomannomutase provides α- D- mannose-1-phosphate from D- mannose-6-phosphate.
α- D- mannose-1-phosphate itself serves to provide GDP-mannose, which either catalyzes a GTP-dependent mannose-1-phosphate guanylyl transferase ( EC 2.7.7.13 ) with consumption of GTP :
Alternatively, a GDP -dependent mannose-1-phosphate-guanylyltransferase ( EC 2.7.7.22 ) can also form GDP-mannose, according to:
pathology
A mutation of phosphomannomutase (PMM-2) leads to a defect, so that sufficient mannose-1-phosphate can no longer be provided. This manifests itself in the fact that many proteins can no longer be modified and leads to a serious disease, the Congenital Disorder of Glycosylation of type 1a (CDG-1a).
literature
- HH Freeze: Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. In: Biochim Biophys Acta . 1792, No. 9, 2009, pp. 835-840, PMID 19339218 , PMC 2783247 (free full text) (Eng.).
Web links
Individual evidence
- ↑ Data sheet α-D (+) Mannose 1-phosphate sodium salt hydrate from Sigma-Aldrich , accessed on May 22, 2017 ( PDF ).
- ↑ Huan Zhou, Lihua Sun, Jian Li, Chunyan Xu, Feng Yu, Yahui Liu, Chaoneng Ji, Jianhua He: The crystal structure of human GDP-l-fucose synthase . In: Acta Biochimica et Biophysica Sinica . tape 45 , no. 9 , January 9, 2013, p. 720-725 , doi : 10.1093 / abbs / gmt066 , PMID 23774504 ( oxfordjournals.org [PDF]).